Insulet (PODD) Acquisitions (2022 - 2023)
Insulet posted quarterly Acquisitions of $3.0 million for Q1 2023, down 88.46% year-on-year from $26.0 million in Q1 2022, and down 88.46% on a QoQ basis from $26.0 million in Q1 2022.
Insulet (PODD) has 2 years of Acquisitions data on file, last reported at $3.0 million in Q1 2023.
- For the quarter ending Q1 2023, Acquisitions fell 88.46% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2023 stood at $3.0 million (down 88.46% YoY), and the FY2023 full-year result was $3.0 million, down 88.46% from the prior year.
- Acquisitions for Q1 2023 stood at $3.0 million, down from $26.0 million in the prior quarter.
- Across five years, Acquisitions topped out at $26.0 million in Q1 2022 and bottomed at $3.0 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -268.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3.00 Mn |
| Mar 31, 2022 | 26.00 Mn |